KatherineTMurrayMD

Adult Congenital Heart Disease, Cardiac Electrophysiology

Professor, Medicine, Vanderbilt University School of Medicine

Dr. Murray is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Dr. Katherine Murray is a cardiologist in Nashville, TN and is affiliated with Vanderbilt University Medical Center. She received her medical degree from Duke University School of Medicine and has been in practice 37 years. She specializes in atrial fibrillation and cardiac electrophysiology and is experienced in cardiac electrophysiology and icd / pacemaker insertion. She has more than 100 publications and over 500 citings.

Duke University HospitalFellowship, Clinical Cardiac Electrophysiology, 1986 - 1987
Duke University HospitalFellowship, Cardiovascular Disease, 1985 - 1986
Vanderbilt University Medical CenterFellowship, Clinical Pharmacology, 1983 - 1985
Vanderbilt University Medical CenterResidency, Internal Medicine, 1980 - 1983
Duke University School of MedicineClass of 1980

PubMed

16 citations
Mortality and concurrent use of opioids and hypnotics in older patients: A retrospective cohort study.
Wayne A. Ray, Cecilia P. Chung, Katherine T. Murray, Beth A. Malow, James R. Daugherty
Plos Medicine. 2021-07-15
240 citations
ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults
William O. Cooper, Laurel A. Habel, Colin M. Sox, K. Arnold Chan, Patrick G. Arbogast
The New England Journal of Medicine. 2011-11-16
1655 citations
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiolo...
Craig T. January, L. Samuel Wann, Hugh Calkins, Lin Y. Chen, Joaquin E. Cigarroa
Journal of the American College of Cardiology. 2019-07-09

J O U R N a L O F T H E a M E R I C a N C O L L E G E O F C a R D I O L O G Y v O L . 6 4 , N O . 2 1 , 2 0 1 4March 4th, 2019
VUMC Joins Research Network to Fight Atrial FibrillationJune 14th, 2018

Azithromycin And Sudden Cardiac Death: Electrophysiologic MechanismsNational Heart, Lung, And Blood Institute2012
Preamyloid Oligomers And Susceptibility To Atrial FibrillationNational Heart, Lung, And Blood Institute2010–2012
A Molecular Target For Atrial FibrillationNational Heart, Lung, And Blood Institute2003–2007
Molecular Targets In Atrial FibrillationNational Heart, Lung, And Blood Institute2002–2005
Molecular Modulation Of Cardiac Na+ Channel FunctionNational Heart, Lung, And Blood Institute2001–2004
Genetic Susceptibility In Acquired Long QT SyndromeNational Center For Research Resources1999–2002
Voltage Gated Cardiac Potassium ChannelsNational Heart, Lung, And Blood Institute1998–2001
Human Cardiac Na+ Channels--Effects Of PhosphorylationNational Heart, Lung, And Blood Institute1997–2000
Cellular Regulation Of Drug/Ion Channel InteractionsNational Heart, Lung, And Blood Institute1993–1996
Metabolic Regulation Of The Cardiac Sodium ChannelNational Heart, Lung, And Blood Institute1990–1994
Cellular Regulation Of Drug-Ion Channel InteractionsNational Heart, Lung, And Blood Institute1992